trial

Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders

NCTId NCT03275766
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 45 (actual)
Sponsored by University of Bern
Primary completion 2019-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
45 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2016-06-01
Primary completion
2019-07-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
DLPFC facilitatorySMA inhibitorySMA facilitatory

Sponsors

University of BernLead Sponsor

Investigators

1
Sebastian Walther, MDPrincipal Investigator

Sites

1 total
Bern, Switzerland

Facts & assertions

4 sourced
Enrollment
45
Phase
NA
Primary Completion Date
2019-07-01
Status
COMPLETED
relationships
The graph out of here
drug
DLPFC facilitatory
drug
SMA inhibitory
drug
SMA facilitatory
drug
lead_sponsor
University of Bern
company
indication
Major Depressive Disorder
indication
Psychomotor Disorders
indication
Psychomotor Slowing
indication
investigator
Sebastian Walther, MD
person